Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma. (2021). Radiology and Oncology, 55(1), 66-76. https://radioloncol.com/index.php/ro/article/view/3516